TABLE 3.

Baseline Characteristics (PHIV With HFpEF)

	HfpEF on PI (n = 57)	HfpEF on NPI (n = 115)	p Value
Female	24 (43)	56 (49)	0.415
BMI, kg/m2	28.0± 5.6	27.0± 5.6	0.272
Age, yrs	60.0± 9.0	60.0± 9.4	0.994
Race
Hispanic	19 (34)	35 (30)	0.701
African American	26 (46)	49 (43)
Others	12 (21)	31 (27)
CV risk factors
Diabetes	26 (45)	40 (35)	0.169
Hypertension	36 (64)	64 (56)	0.348
Hyperlipidemia	31 (54)	40 (35)	0.014
Smoking	20 (35)	59 (51)	0.044
CAD	28 (49)	33 (29)	0.008
Myocarditis	8 (14)	13 (11)	0.626
Cocaine	26 (46)	32 (28)	0.020
SBP, mm Hg	144.0± 25.8	141.0± 26.6	0.483
DBP, mm Hg	78± 18.8	79± 18.2	0.737
Heart rate, beats/min	80.0± 23.2	82.0± 22.7	0.590
PASP, mm Hg	47.0± 9.9	40.0± 8.1	<0.001
LVEF, %	57.0± 5.3	56.0± 5.0	0.231
SA	16 (28)	36 (31)	0.663
HCV	11 (20)	25 (22)	0.711
HIV parameters
CD4 count at 1st HF admission, cells/mm3	276± 215	291± 193	0.645
Nadir CD4 count, cells/mm3	218± 185	272± 191	0.080
VL <200 copies/ml	34 (60)	72 (63)	0.707
Duration of ART, yrs	8 (4–14)	9 (4–14)	0.842
Duration of PI, yrs	6 (4–11)	–	–
Duration of HIV*	8 (4–14)	9 (4–14)	0.842
Duration of untreated HIV†	75 (46–104)	74 (46–106)	0.632
Socioeconomic parameters
High school or GED completion	38 (66)	72 (63)	0.601
Unemployment	7(13)	14 (12)	0.983
ART medications
NRTIs	57 (100)	115 (100)	>0.05
INSTIs	3(5)	44 (38)	<0.001
NNRTIs	4(7)	71 (62)	<0.001
HF medications
Beta-blocker	48 (85)	102 (89)	0.468
ACE inhibitor or ARB	47 (83)	99 (86)	0.651
Spironolactone	0(0)	0(0)
Furosemide	39 (69)	92 (80)	0.093

Values are n (%), mean± SD, or median (interquartile range). Bold p values are statistically significant.

^*Duration of HIV is in years.

^†Duration of untreated HIV is the duration before starting ART after the diagnosis in days.

HFpEF = heart failure with preserved ejection fraction; other abbreviations as in Table 1.